NNNN

Anbio Biotechnology Class A Ordinary SharesNASDAQHealthcare

$25.85+0.54%ClosedMarket Cap: $1.13B

As of 2026-04-06

Valuation

P/E (TTM)

401.87

PEG

—

P/B

35.08

P/S

150.57

EV/EBITDA

399.65

DCF Value

$0.53

FCF Yield

0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

89.7%

Operating Margin

25.8%

Net Margin

37.5%

ROE

11.4%

ROA

8.7%

ROIC

6.0%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q2 2025	$5.0M	92.3%	$3.7M	$4.1M	$0.09	—
Q4 2024	$2.5M	84.6%	$-1.7M	$-1.3M	$-0.03	—
FY 2024	$8.2M	71.9%	$2.0M	$2.4M	$0.06	—
Q2 2024	$6.3M	66.9%	$3.9M	$3.9M	$0.09	—
Q4 2023	$4.0M	42.8%	$583.7K	$792.9K	$0.02	—
FY 2023	$6.7M	50.1%	$2.0M	$2.3M	$0.01	—
Q2 2023	$3.3M	58.7%	$1.5M	$1.6M	$0.04	—
FY 2022	$23.5M	53.4%	$10.2M	$10.0M	$0.07	—
FY 2021	$4.4M	57.4%	$2.5M	$2.5M	$0.03	—